Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression
Hunan Province Tumor Hospital
Hunan Province Tumor Hospital
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Fox Chase Cancer Center
EpicentRx, Inc.
AstraZeneca
Shaare Zedek Medical Center
Shanghai Pulmonary Hospital, Shanghai, China
EMD Serono
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
The Netherlands Cancer Institute
Dana-Farber Cancer Institute
Third Military Medical University
New Mexico Cancer Research Alliance
Louisiana State University Health Sciences Center Shreveport
University of Alabama at Birmingham
National Cancer Institute (NCI)
SWOG Cancer Research Network
SWOG Cancer Research Network
SWOG Cancer Research Network
National Cancer Institute (NCI)
Scripps Health
Eli Lilly and Company
National Cancer Institute (NCI)